Mainz Biomed B.V. Made Big Gain

Fri, Jan 21, 2022 at 05:35 PM

Mainz Biomed B.V. (MYNZ:NASDAQ) soared at $27.76, a gain of 16.9%. The stock appeared on our News Catalysts scanner on Wed, Jan 19, 2022 at 03:25 AM in the 'BIOTECH' category. From Fri, Jan 07, 2022, the stock recorded 62.50% Up Days and 66.67% Green Days

The stock spiked on Tue, Jan 18, 2022 at $30 with a volume of 2M+.

About Mainz Biomed B.V. (MYNZ:NASDAQ)

Mainz Biomed BV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions.

Top 10 Gainers:

Canna-Global Acquisition Corp (CNGL:NASDAQ), 100%
Pintec Technology Holdings Limited (PT:NASDAQ), 55.31%
BBQ Holdings, Inc. (DAVE:NASDAQ), 30.25%
CF Acquisition Corp. V (CFV:NASDAQ), 30.2%
Save Foods Inc. (SVFD:NASDAQ), 25.6%
Vistas Media Acquisition Company Inc. (VMAC:NASDAQ), 25.38%
Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ), 20.3%
Mainz Biomed B.V. (MYNZ:NASDAQ), 16.88%
Eco Wave Power Global AB (publ) (WAVE:NASDAQ), 16.43%
Gelesis Holdings Inc. (GLS:NYSE), 15.11%